Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01829711
Recruitment Status : Active, not recruiting
First Posted : April 11, 2013
Last Update Posted : May 15, 2018
Information provided by (Responsible Party):
MedImmune LLC